$32.24 0.24 (+0.75%)
11/6/2009 4:00 PM

Bio-Reference Laboratories, Inc. (BRLI)

CAPS Rating: 5 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Current Price $32.24 Mkt Cap $445.84M
Open $31.79 P/E Ratio 22.22
Prev. Close $32.00 Div. (Yield) N/A (N/A)
Daily Range $31.50 - $32.43 Volume 56,244
52-Wk Range $18.35 - $36.25 Avg. Daily Vol. 88,000

BRLI News and Commentary

Caps

How do you think BRLI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

160 Outperform
9 Underperform
 

All-Star Members

49 Outperform
0 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top BRLI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

thestinkyfeet (94.39)
Submitted August 02, 2008

The reasoning behind the selection of this stock, and a board on which to discuss the stock, or whatever else you like, can be found on the MF Stinky Feet discussion board at http://boards.fool.com/Messages.asp?mid=26829411&bid=119057&days=7… More

ac11166 (< 20)
Submitted August 29, 2006

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

BRLI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about BRLI.

Recs

0
Member Avatar EBStroke (< 20) Submitted: 11/6/2009 10:34:21 AM : Outperform Start Price: $32.04 BRLI Score: +0.08

Zacks Rank 4-Sell, Recommend Neutral, Ind Rank 100 / 217, Target 36.60, Avg of 5 analysts 35.17

Recs

0
Member Avatar HLChin (81.84) Submitted: 10/23/2009 3:28:30 PM : Outperform Start Price: $34.55 BRLI Score: -5.99

I put this on CAPs as a test because I believe that CEOs who put better science and better service as primary goals will succeed in a stock market filled with bean-counters. And that profitability and growth will follow
- CEO Marc D. Grodman holds 11% of the stock
- Differentiated diagnostic tests
- $15m cash, $30m debt but with 20 times interest coverage

Risks - Medicare provided 25% of revenue

"Grow or die"

Recs

0
Member Avatar marketmomentum (26.52) Submitted: 8/10/2009 6:47:17 PM : Underperform Start Price: $29.85 BRLI Score: -0.95

No need for them after H1N1 gets you.

Leaderboard

Find the members with the highest scoring picks in BRLI.

Score Leader

dsks68

dsks68 (< 20) Score: +66.03

The Score Leader is the member with the highest score across all their picks in BRLI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
kd554 < 20 8/28/2006 Outperform 1Y $20.92 +54.11% -11.92% +66.03
dsks68 < 20 8/28/2006 Outperform 3Y $20.92 +54.11% -11.92% +66.03 1 Comment
tomkat104 82.01 8/29/2006 Outperform 5Y $21.06 +53.09% -12.05% +65.14
PapaMan200 87.61 8/29/2006 9/7/2006 Outperform 5Y $21.06 +53.09% -11.85% +64.94
bigreenmountain < 20 1/23/2007 Outperform 3Y $22.43 +43.74% -20.07% +63.81
boyet7 89.08 10/4/2006 Outperform 1Y $21.79 +47.96% -14.49% +62.44 1 Comment
dfox20 < 20 10/6/2006 Outperform 3Y $21.93 +47.01% -15.41% +62.43
blanders52411 57.68 10/12/2006 Outperform 3M $22.12 +45.75% -16.11% +61.86
NetscribeHealthC 20.20 1/31/2007 Outperform 1Y $22.78 +41.53% -20.28% +61.80 1 Comment
mjl75 86.71 1/8/2007 Outperform 5Y $22.65 +42.34% -19.24% +61.58

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackOppenheimer 26.63 5/29/2008 Outperform NS $25.33 -3.63% -33.96% +30.33 1/9/2009 @ $24.41
TrackWMBlair 39.74 2/21/2008 Outperform NS $28.92 +11.50% -17.90% +29.40
TrackJefferies 75.83 1/16/2007 Outperform NS $23.74 +23.46% -33.35% +56.82 6/5/2009 @ $29.31
TrackJimCramer < 20 12/20/2006 Underperform 3W $22.98 +40.30% -19.97% -60.27

Featured Broker Partners